1C
ARVN icon

111 Capital’s Arvinas ARVN Stock Holding History

111 Capital’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,926
Closed -$95.1K – 461
2025
Q2 		$95.1K Buy
+12,926
New +$95.2K 0.02% 481

Other funds holding ARVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

111 Capital's ARVN Position: Q3 2025 in Review

111 Capital sold out of Arvinas (ARVN) in Q3 2025, closing a stake of 12,926 shares — an estimated $95.1K sold.

111 Capital first reported a position in ARVN in Q2 2025 and held it in 1 quarter. The position peaked at $95.1K in Q2 2025. 211 funds tracked by Wall St. Rank hold ARVN as of Q3 2025.

  • 111 Capital reported no remaining Arvinas position as of Q3 2025 after selling out during the quarter.
  • 111 Capital sold 12,926 Arvinas shares in Q3 2025, an estimated $95.1K.
  • 111 Capital first reported a position in Arvinas in Q2 2025 and held it in 1 quarter.
  • 111 Capital's Arvinas position peaked at $95.1K in Q2 2025.
  • 211 funds tracked by Wall St. Rank held Arvinas as of Q3 2025.

Based on 111 Capital's 13F filing for Q3 2025, filed 12 Nov 2025.